Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira

Optimizing prognosis in atrial fibrillation: A call to action in Portugal Jorge Ferreira, Natália António, Nuno Cortez-Dias, Luciana Ricca Gonçalves, João Sargento-Freitas, Pedro von Hafe, Victor Gil

Update on the efficacy of statins in primary and secondary prevention of atrial fibrillation Alireza Oraii, Ali Vasheghani-Farahani, Saeed Oraii, Pegah Roayaei, Pargol Balali, Farzad Masoudkabir